Women’s Hormonal Health Issues


Composition

Product name

FDA-approved dosage

Vaginal creams

17β-estradiol

Estrace vaginal cream®

Initial: 2–4 g/day for 1–2 weeks

maintenance: 1 g/1–3 times/week

Conjugated estrogens

Premarin vaginal cream®

For VVA: 0.5–2 g/day for 21 day then off 7 d

for dyspareunia: 0.5 g/d for 21 day then off 7 day, or twice/week

Estrone

Estragyn vaginal cream®

2–4 g/day; intended for short-term use; progestogen recommended

Vaginal rings

17β-estradiol

Estring®

Device containing 2 mg releases approximately 7.5 µg/day for 90 day

Estradiol acetate

Femring®

Device containing 12.4 mg or 24.8 mg estradiol acetate releases 0.05 mg/day or 0.1 mg/day estradiol for 90 days

Vaginal tablet

Estradiol hemihydrate

Vagifem®

Initial: 1 tablet/day for 2 weeks

Only gold members can continue reading. Log In or Register to continue

Related posts:

Default ThumbnailConditioning Regimens Default ThumbnailTransfusion Medicine Default ThumbnailEngraftment Default ThumbnailCardiovascular Complications Default ThumbnailPsychiatric Complications Default ThumbnailLong-Term Follow-Up and Survivorship

Stay updated, free articles. Join our Telegram channel
Tags:
Jun 23, 2017 | Posted by in HEMATOLOGY | Comments Off on Women’s Hormonal Health Issues

Full access? Get Clinical Tree
Get Clinical Tree app for offline access